Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/29207

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29207

题名:	Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan
作者:	Peng, CT;Chow, KC;Chen, JH;Chiang, YP;Lin, TY;Tsai, CH
贡献者:	附設醫院兒科部;China Med Coll Hosp, Dept Paediat, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Taichung 404, Taiwan;China Med Coll Hosp, Dept Radiol, Taichung 404, Taiwan;China Med Coll Hosp, Dept Pathol, Taichung 404, Taiwan;China Med Coll Hosp, Inst Med Sci, Taichung 404, Taiwan
日期:	2003
上传时间:	2010-09-24 14:27:01 (UTC+8)
出版者:	BLACKWELL MUNKSGAARD
摘要:	Current serological tests for melioidosis, using impure or uncharacterized cell antigens from Burkholderia pseudomallei, have problems in detection sensitivity and specificity. Therefore, we designed and expressed the recombinant flagellin (truncated at both the N- and C-terminal ends), and used the antigen to develop an indirect enzyme-linked immunosorbent assay (ELISA) to diagnose melioidosis. Comparison of the immunoreactivities of the full-length and truncated flagellins reveals that the truncated flagellin performed much better in detection specificity and sensitivity. Only the full-length flagellin was recognized by other bacterial causing septicemia and gave a false-positive result in Western analysis, indicating that the cross-reactive epitopes were located on the more highly conserved N- and C-terminal regions of flagellin. The indirect ELISA using recombinant truncated flagellin as the antigen achieved 93.8% sensitivity and 96.3% specificity and offered a more efficient serodiagnosis of melioidosis.
關聯:	EUROPEAN JOURNAL OF HAEMATOLOGY 70(6):392-397
显示于类别:	[台中附設醫院] 期刊論文

文件中的档案:

没有与此文件相关的档案.

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....